Готові списки джерел за темами / Drug-resistant infections

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Drug-resistant infections"

Автор: Grafiati
Опубліковано: 3 червня 2025
Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Drug-resistant infections".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Drug-resistant infections"

1

Patrick, Christian C. "Drug-resistant staphylococcal infections." Seminars in Pediatric Infectious Diseases 7, no. 3 (1996): 182–86. http://dx.doi.org/10.1016/s1045-1870(96)80006-9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Woods, Charles R., and Laurence B. Givner. "Drug-resistant meningococcal infections." Seminars in Pediatric Infectious Diseases 7, no. 3 (1996): 204–11. http://dx.doi.org/10.1016/s1045-1870(96)80008-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Hoppe, B. "Control of infections caused by drug-resistant organisms in critical care." American Journal of Critical Care 6, no. 2 (1997): 141–44. http://dx.doi.org/10.4037/ajcc1997.6.2.141.

Повний текст джерела
Анотація:
The emergence of antibiotic-resistant pathogens has been an ongoing concern of infection-control and infectious disease practitioners. Infections caused by these organisms increase costs and may result in poorer outcomes for patients. Efforts to contain the problem of infections caused by drug-resistant organisms have two objectives: to optimize antibiotic use and to prevent transmission through effective infection-control practices.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Weese, J. S. "A review of multidrug resistant surgical site infections." Veterinary and Comparative Orthopaedics and Traumatology 21, no. 01 (2008): 1–7. http://dx.doi.org/10.3415/vcot-07-11-0106.

Повний текст джерела
Анотація:
SummarySurgical site infections caused by bacteria that are resistant to multiple classes of antimicrobials are an important and increasing problem in veterinary medicine. Organisms such as methicillin-resistant staphylococci, extended spectrum beta-lactamase Enterobacteriaceae and multi-drug resistant Enterococcus, Acinetobacter and Pseudomonas spp. are among the current concerns; however, the emergence and dissemination of other multi-drug resistant organisms will likely follow. Despite the negative connotations that are associated with multi-drug resistant infections, most infections are po
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Potera, Carol. "Tackling Drug-Resistant Bacterial Infections." Genetic Engineering & Biotechnology News 32, no. 8 (2012): 8–10. http://dx.doi.org/10.1089/gen.32.8.02.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Dorrell, Sharon. "Overcoming drug-resistant yeast infections." Drug Discovery Today 7, no. 6 (2002): 332–33. http://dx.doi.org/10.1016/s1359-6446(02)02221-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Jacobs, Richard F. "Introduction: Drug-resistant bacterial infections." Seminars in Pediatric Infectious Diseases 7, no. 3 (1996): 156. http://dx.doi.org/10.1016/s1045-1870(96)80002-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sanford, Jay P., and Edward C. Rosenow. "Combating Drug-Resistant Pneumococcal Infections." Hospital Practice 29, no. 10 (1994): 31–37. http://dx.doi.org/10.1080/21548331.1994.11443087.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Shrestha, Lok Bahadur, Narayan Raj Bhattarai, and Basudha Khanal. "Bacteriological Profile and Antimicrobial Susceptibility Pattern among Isolates Obtained From Body Fluids." Journal of Nepal Health Research Council 17, no. 2 (2019): 173–77. http://dx.doi.org/10.33314/jnhrc.v0i0.1656.

Повний текст джерела
Анотація:
Background: Infections of the sterile body sites, when occurs typically have greater clinical urgency and these infections could be life threatening. For the appropriate management of patient, early detection and identification of organism is crucial. Hence, the present study was designed to evaluate the prevalence, organism profile and antimicrobial susceptibility pattern of isolates obtained from infection of body fluids.Methods: Laboratory and clinical records of all the sterile body fluid except blood and cerebrospinal fluid submitted to the Department of Microbiology, B. P. Koirala Instit
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Nastri, Bianca Maria, Pasquale Pagliano, Carla Zannella, et al. "HIV and Drug-Resistant Subtypes." Microorganisms 11, no. 1 (2023): 221. http://dx.doi.org/10.3390/microorganisms11010221.

Повний текст джерела
Анотація:
Acquired Immunodeficiency Syndrome (AIDS) is a human viral infectious disease caused by the positive-sense single-stranded (ss) RNA Human Immunodeficiency Virus (HIV) (Retroviridae family, Ortervirales order). HIV-1 can be distinguished into various worldwide spread groups and subtypes. HIV-2 also causes human immunodeficiency, which develops slowly and tends to be less aggressive. HIV-2 only partially homologates to HIV-1 despite the similar derivation. Antiretroviral therapy (ART) is the treatment approved to control HIV infection, based on multiple antiretroviral drugs that belong to differ
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Drug-resistant infections"

1

Delespaux, Vincent F. P. "Improved diagnosis of trypanosome infections and drug resistant T.congolense in livestock." Doctoral thesis, Universite Libre de Bruxelles, 2005. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/211060.

Повний текст джерела
Анотація:
The aim of this thesis was to provide a picture of the trypanosomosis and drug resistance prevalence in Eastern Province of Zambia, to understand the underlying factors of drug resistance (drug use habits), to improve the diagnosis of trypanosomosis in livestock and finally, to improve the diagnosis of isometamidium resistance in T.congolense. After an introductory part where available trypanosomosis and trypanocide resistance diagnostic methods are described and discussed, the body of the thesis is divided in two main sections. In the first section are presented the results of a cross-section
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Phee, Lynette. "Unorthodox antimicrobial combination therapies for the treatment of multi-drug resistant Gram-negative infections." Thesis, Queen Mary, University of London, 2018. http://qmro.qmul.ac.uk/xmlui/handle/123456789/44695.

Повний текст джерела
Анотація:
The rise of antimicrobial resistance (AMR) has culminated in the most pressing problem in modern medicine. The situation is most acute with regards to the management of multi- drug resistant Gram-negative infections (MDRGNB) with common infections increasingly untreatable due to rapidly dwindling therapeutic options. A solution to the problem of AMR is unlikely to be easily found, but revisiting and re-purposing existing antimicrobials is a viable approach in the medium term. This study investigated the use of unorthodox antimicrobial combination therapies for the treatment of MDRGNB, with par
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Drennon, Michael T. "Drug resistant patterns of invasive Streptococcus pneumoniae infections in the State of Florida in 2003." [Tampa, Fla] : University of South Florida, 2006. http://purl.fcla.edu/usf/dc/et/SFE0001455.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Gounden, Ronald. "Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections." Master's thesis, University of Cape Town, 2009. http://hdl.handle.net/11427/3282.

Повний текст джерела
Анотація:
Includes bibliographical references (leaves 42-47).<br>Background: Nosocomial infections due to multi-drug resistant Acinetobacter baumannii are often treated with colistin, but there are few data comparing its safety and effectiveness with other antimicrobials, particularly the aminoglycosides. Metbods: A retrospective cohort study of patients treated with colistin or tobramycin for A. baumannii infections in intensive care units (ICUs) at Groote Schuur hospital was performed. Colistin was used for A baumannii isolates which were resistant to all other available antimicrobials. Tobramycin was
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Dandachi, Iman. "Multi drug resistant organisms in Lebanese livestock." Thesis, Aix-Marseille, 2018. http://www.theses.fr/2018AIXM0286/document.

Повний текст джерела
Анотація:
De nos jours, l'épidémiologie des bactéries multi-résistantes a évolué et ne se limite plus aux milieux hospitaliers. En effet, les animaux sont désormais considérés comme d’importants réservoirs de bactéries multi-résistantes, notamment des Bacilles à Gram négatif sécréteurs de bêta-lactamases et/ou résistant à la colistine. L'émergence de ces bactéries chez les animaux est due principalement à l’utilisation excessive d’antibiotiques en tant que prophylaxie et facteurs de croissance. Le transfert d’organismes multi-résistants aux antibiotiques provenant d’animaux vers les humains est un probl
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Okleberry, Kevin M. "Metabolism of Selected Antiviral Agents in Cells Infected with Drug-Resistant and Wild-Type Strains of Murine Cytomegalovirus." DigitalCommons@USU, 1995. https://digitalcommons.usu.edu/etd/4657.

Повний текст джерела
Анотація:
Resistance of human viral pathogens to various antiviral drugs is a serious medical problem. Two modes of drug resistance in cytomegalovirus infections have been observed, the first being altered (decreased) drug metabolism by the infected cells, and the second reduced sensitivity of the viral deoxyribonucleic acid polymerase enzyme to the active form of the drug. Mice infected with the murine cytomegalovirus have been used extensively as an animal model for the human cytomegalovirus, and drug-resistant strains in this model have been identified. To better understand the mode of drug resistanc
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zahar, Jean-Ralph. "Epidémiologie et conséquences des infections nosocomiales en réanimation : Impact et conséquences de la résistance bactérienne en réanimation." Thesis, Grenoble, 2012. http://www.theses.fr/2012GRENS004/document.

Повний текст джерела
Анотація:
Les infections nosocomiales à bactéries multi-résistantes sont en constante augmentation en réanimation. Elles ont des conséquences individuelles et collectives majeures. La mortalité en réanimation et les prolongations des durées de séjour sont les deux principales conséquences individuelles connues à ce jour. Plusieurs facteurs confondants rendent l'interprétation des études difficiles, dont l'état sous jacent du patient, la virulence de la bactérie et l'adéquation thérapeutique. Mesurer la part de chacun de ces facteurs et préciser leur responsabilité respective est indispensable pour mobil
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Khachatryan, Artashes Ruben. "Mechanisms responsible for the maintenance of high prevalence of antimicrobial drug resistant Escherichia coli in dairy calves." Online access for everyone, 2005. http://www.dissertations.wsu.edu/Dissertations/Fall2005/a%5Fkhachatryan%5F121205.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Machado, Lisa Santos. "The inhibitory activity of synthetic compounds and ions against transporters of multi-drug resistant bacteria." Master's thesis, Faculdade de Ciências Médicas. Universidade Nova de Lisboa, 2011. http://hdl.handle.net/10362/7712.

Повний текст джерела
Анотація:
RESUMO: Sessenta e três derivados de hidantoína foram utilizados para avaliar possíveis efeitos de modulação na actividade das bombas de efluxo (BE) na Salmonella NCTC 13349 utilizando um método fluorimétrico semi-automático. Nenhum dos compostos apresentaram actividade anti-bacteriana até concentrações de 240 mg/L. Entre todos os compostos, SZ-7 demonstrou possuir propriedades de modulação de effluxo na presença de glucose. Para testar esta actividade, estirpes de Salmonella resistentes à ciprofloxacina, induzidas a elevados níveis de resistência com sobre-expressão de BE, foram expostas ao S
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Wilson, Geneva Marion. "Environmental and pharmaceutical risk factors for the transmission of Clostridium difficile and other multi-drug resistant hospital acquired infections." Diss., University of Iowa, 2019. https://ir.uiowa.edu/etd/6885.

Повний текст джерела
Анотація:
Clostridium difficile (C. difficile) is a gram positive, anaerobic, spore forming bacterium. C. difficile infections are triggered by dysbiosis of the intestinal microbiome linked to age, immune status, and medication; particularly use of antibiotics and proton pump inhibitors (PPI). The spore forming nature of the bacteria gives it the ability to persist in the environment for long periods of time and makes it impervious to many commonly-used hospital cleaning and disinfection products. C. difficile, along with Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Entero
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Drug-resistant infections"

1

Gillespie, Stephen H., ed. Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

H, Gillespie S., ed. Management of multiple drug-resistant infections. Humana Press, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Pogorzelska, Monika. Institutional and Patient Level Predictors of Multi-Drug Resistant Healthcare-Associated Infections. [publisher not identified], 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

West, Katherine H. The new threat of drug-resistant microbes: The return of untreatable common infections? 2nd ed. Western Schools Press, 1994.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development., and United States. Agency for International Development., eds. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. World Health Organization, Stop TB Department, 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development., and United States. Agency for International Development., eds. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. World Health Organization, Stop TB Department, 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zumla, Alimuddin, David S. C. Hui, and Wing-Wai Yew. Emerging respiratory infections in the 21st century. Saunders, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

A, Weigelt John, ed. MRSA. 2nd ed. Informa Healthcare, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

A, Miller Debra, ed. Resistant infections. Greenhaven Press, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

World Health Organization (WHO). Management of MDR-TB: A field guide, a companion document to Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Drug-resistant infections"

1

Schluger, Neil W. "Extensively Drug-Resistant Tuberculosis." In Emerging Infections 8. ASM Press, 2014. http://dx.doi.org/10.1128/9781555815592.ch17.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jenks, Peter J. "Drug-Resistant Helicobacter pylori." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Seaworth, Barbara J., and David E. Griffith. "Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis." In Tuberculosis and Nontuberculous Mycobacterial Infections. ASM Press, 2017. http://dx.doi.org/10.1128/9781555819866.ch9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Clements, Sanya, and Christopher C. Kibbler. "Management of Resistant Candida Infections." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Pillay, Deenan. "Management of HIV Drug-Resistant Infections." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_20.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Doenhoff, Michael J., and Katherine Wheatcroft-Francklow. "Schistosome Drug Resistance." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ashley, Elizabeth, and François Nosten. "Management of Multiple Drug-Resistant Malaria." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Parry, Christopher M. "Management of Multiple Drug-Resistant Salmonella Infections." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Peter, A., and R. Wilson. "Management of Glycopeptide-Resistant Staphylococcus aureus Infections." In Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Davies, Geraint Rhys. "Multi-drug Resistant Tuberculosis in Travellers." In Emerging and Re-emerging Infections in Travellers. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-49475-8_21.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Drug-resistant infections"

1

Jonnalagadda, Keertana, Rachel Carr, and Valerie Carabetta. "Evaluation of the Efficacy of Novel Drugs and Combinations Against Extensively- and Pan-Drug Resistant Acinetobacter baumannii Isolates." In 28th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2024. http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.110_2024.

Повний текст джерела
Анотація:
Acinetobacter baumannii, a Gram-negative, nosocomial, opportunistic pathogen is commonly infectious in immunocompromised patients. More specifically patients develop healthcare-associated infections (HAI) spanning beyond sepsis, pneumonia, meningitis, and urinary tract infections. Due to its rapid ability to acquire antibiotic resistance, it has raised the necessity to discern a novel therapeutic treatment that can be effectively used against the multidrug resistant (MDR) A. baumannii. Cooper University Hospital (CUH) faced an increased case load of patients that were infected with MDR A. baum
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Carr, Rachel, Justin Halim, Rebecca Fliorent, Henry Fraimow, Dejan Nikolic, and Valerie Carabetta. "Characterization of Antibiotic Susceptibility Profiles of Extensively- and Pan-Drug Resistant Acinetobacter Baumannii Clinical Isolates." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.96_2023.

Повний текст джерела
Анотація:
Acinetobacter baumannii is an opportunistic pathogen common in intensive care units (ICUs), particularly among immunocompromised individuals. Nosocomial A. baumannii infections have become increasingly problematic in recent years, as these bacteria rapidly acquire antibiotic resistance, leading to the emergence of multidrug, extensively drug and pan drug-resistant (MDR, XDR, and PDR, respectively) isolates. Recently, Cooper University Hospital (CUH) experienced a large increase in highly drug-resistant A. baumannii infections, which had a mortality rate of 60%. Oftentimes, physicians had to tu
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Novak, Sonja, Nadežda Popović, Nikola Milenković, Nataša Lukić, and Bojan Stanojević. "Surveillance of hospital-acquired infections at the Niš University Clinical Center: Analysis of isolates with multidrug-resistant bacteria." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24038n.

Повний текст джерела
Анотація:
Background: It is important for healthcare facilities to have robust infection control measures in place to minimize the risk of hospital-acquired infections (HAI) and protect patient safety. By analyzing multidrug resistant bacteria, healthcare professionals can make informed decisions about antibiotic therapy, implement appropriate infection control measures to prevent the spread of resistant strains, and contribute to the development of new antimicrobial agents. The aim of the study was to investigate the microbial isolates in humane materials and compare findings with number of registered
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Jokerst, Jesse V., Taeho Kim, and Yash Mantri. "A hybrid nanoparticle to diagnose and treat multi-drug resistant bacteria (Conference Presentation)." In Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2019, edited by Tianhong Dai, Mei X. Wu, and Jürgen Popp. SPIE, 2019. http://dx.doi.org/10.1117/12.2511157.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Sharma, Deepika. "Novel Natural and Synthetic Anticandidal Therapeutic Peptides to Combat Drug-Resistant Infections." In ECA 2023. MDPI, 2023. http://dx.doi.org/10.3390/eca2023-16385.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Sallum, Ulysses W., Xiang Zheng, Sarika Verma, and Tayyaba Hasan. "Exploiting bacterial drug resistance: a single construct for the diagnosis and treatment of drug resistant infections." In 12th World Congress of the International Photodynamic Association, edited by David H. Kessel. SPIE, 2009. http://dx.doi.org/10.1117/12.828202.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Gelfand, Jeffery A., Yingying Huang, Anton Wintner, et al. "Drug-resistant catheter-associated urinary tract Infection (CAUTI): an enlightened therapeutic approach (Conference Presentation)." In Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2019, edited by Tianhong Dai, Mei X. Wu, and Jürgen Popp. SPIE, 2019. http://dx.doi.org/10.1117/12.2507562.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Quraish, Zainab Sahib A., and Fatimah Sahib Abuhanen. "Multi-drug resistance in methicillin resistant Staphylococcus aureus (MRSA) isolated from diabetic foot infections." In TRANSPORT, ECOLOGY, SUSTAINABLE DEVELOPMENT: EKO VARNA 2023. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0191541.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

MAJEED, Huda Zuheir, Firas Nabeeh JAAFAR, Mohammed Twfeek ABID ALHUSAIN, Shatha Zuheir MAJEED, and Nadia Kamil BASHAR. "THE ANTIBACTERIAL EFFECTS OF GREEN TEA EXTRACT ON RESISTANT BACTERIA ISOLATED FROM HUMAN EYE INFECTIONS." In IV.International Scientific Congress of Pure,Appliedand Technological Sciences. Rimar Academy, 2022. http://dx.doi.org/10.47832/minarcongress4-28.

Повний текст джерела
Анотація:
Ocular infection is a world wide issue especially for public health field which could be a result to its own normal flora due to subjection to external factors (e.g. stress, getting older, hits, surgical operations, systemic diseases and losing commensal flora). Ocular pathogens could be healed by a group of topical antibiotics, but with time, drug resistance had been developed, which more magnified by wrong diagnosis and random use of antibiotics leading to unexpected complications e.g. visual problems, leading to blindness at last . Alternative therapy had been used to treat such infections
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Wright, Francesca, Louise Anning, and Bianca Hulance. "Bedaquiline in the treatment of multi-drug resistant non-tuberculous mycobacteria soft tissue infections: a case series." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa3087.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Drug-resistant infections"

1

Gulick, Andrew M., Thomas A. Russo, L. W. Schultz, and Timothy C. Umland. Identification of New Drug Targets in Multi-Drug Resistant Bacterial Infections. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada610780.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gulick, Andrew M., Thomas A. Russo, L. W. Schulz, and Timothy C. Umland. Identification of New Drug Targets in Multi-Drug Resistant Bacterial Infections. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada610991.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Masoambeta, Edward, Charity Mkwanda, Edna Ibrahim, et al. ECONOMIC COSTING METHODOLOGIES OF DRUG RESISTANT BACTERIA INFECTIONS IN LOW-AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.7.0004.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Maraolo, Alberto Enrico, and David SY Ong. Colistin plus meropenem versus colistin alone for invasive infections caused by Carbapenem-Resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0055.

Повний текст джерела
Анотація:
Review question / Objective: What is the benefit stemming from meropenem add-on treatment to colistin against Carbapenem-Resistant strains of Acinetobacter baumannii? Condition being studied: Invasive infections caused by extensively drug-resistant (XDR) Acinetobacter baumannii, specifically carbapenem-resistant Acinetobacter baumannii (CRAB), are associated with high mortality above 50%, especially in critically ill patients. Often colistin is the only active agent in vitro and, although its safety issues, remains the cornerstone of therapy. Nevertheless, considering the relevant mortality ra
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Perlin, David S. Evaluation of Carbohydrate-Derived Fulvic Acid (CHD-FA) as a Topical Broad-Spectrum Antimicrobial for Drug-Resistant Wound Infections. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada599044.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

James, Christian, Stephen J. James, Bukola A. Onarinde, Ronald A. Dixon, and Nicola Williams. Critical review of AMR risks arising as a consequence of using biocides and certain heavy metals in food animal production. Food Standards Agency, 2023. http://dx.doi.org/10.46756/sci.fsa.ich936.

Повний текст джерела
Анотація:
Antimicrobial resistance (AMR) is the resistance of a microorganism to an antimicrobial agent (a substance that kills or stops the growth of microorganisms) that was originally effective for treatment of infections caused by it. As a result standard antimicrobial drug treatments may become ineffective, lead to infections persisting, increasing the risk of spread to others, and negative clinical outcomes. AMR is a major public health issue worldwide and it is estimated that unless action is taken to tackle AMR, the global impact of AMR could be 10 million deaths annually from drug-resistant inf
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Rosa-Mangeret, Flavia, Otis Olela, Francisca Barcos-Munoz, et al. Drug Resistant Bacterial Neonatal Early Onset Sepsis in Africa: A 20 year- prevalence review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.1.0112.

Повний текст джерела
Анотація:
Review question / Objective: What is the prevalence of drug-resistant pathogens associated with neonatal Early Onset Sepsis (NEOS) in the African continent and their likelihood of resistance to commonly used antibiotics in the NEOS, and what is the trend through time? Condition being studied: There is no consensus on the definition of neonatal sepsis. Two main categories of neonatal sepsis are widely accepted: early-onset sepsis (EOS) defined as occurring in the first 72 hours of life, hence representing perinatal vertical infection; and late-onset sepsis (LOS), which occurs between 72 hours t
Стилі APA, Harvard, Vancouver, ISO та ін.
8

MSF Access, Campaign. DR-TB drugs under the microscope 2022. Doctors Without Borders/Médecins Sans Frontières, 2022. http://dx.doi.org/10.57740/zxbm-0414.

Повний текст джерела
Анотація:
TB was the leading cause of death from a single infectious agent until the COVID pandemic. The number of people newly diagnosed with TB in 2020 fell by 18% from the previous year due to disruptions to health systems and services caused by the pandemic, with only a partial recovery in 2021. As a result, in 2021, only one in three people with drug-resistant TB (DR-TB) received treatment for the disease. However, since the onset of the pandemic, more effective and patient-friendly treatments and regimens for adults and children have become available to the TB community. Now more than ever there i
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Willis, C., F. Jorgensen, S. A. Cawthraw, et al. A survey of Salmonella, Escherichia coli (E. coli) and antimicrobial resistance in frozen, part-cooked, breaded or battered poultry products on retail sale in the United Kingdom. Food Standards Agency, 2022. http://dx.doi.org/10.46756/sci.fsa.xvu389.

Повний текст джерела
Анотація:
Frozen, breaded, ready-to-cook chicken products have been implicated in outbreaks of salmonellosis. Some of these outbreaks can be large. For example, one outbreak of Salmonella Enteritidis involved 193 people in nine countries between 2018 and 2020, of which 122 cases were in the UK. These ready-to-cook products have a browned, cooked external appearance, which may be perceived as ready-to-eat, leading to mishandling or undercooking by consumers. Continuing concerns about these products led FSA to initiate a short-term (four month), cross-sectional surveillance study undertaken in 2021 to det
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Cahaner, Avigdor, Susan J. Lamont, E. Dan Heller, and Jossi Hillel. Molecular Genetic Dissection of Complex Immunocompetence Traits in Broilers. United States Department of Agriculture, 2003. http://dx.doi.org/10.32747/2003.7586461.bard.

Повний текст джерела
Анотація:
Objectives: (1) Evaluate Immunocompetence-OTL-containing Chromosomal Regions (ICRs), marked by microsatellites or candidate genes, for magnitude of direct effect and for contribution to relationships among multiple immunocompetence, disease-resistance, and growth traits, in order to estimate epistatic and pleiotropic effects and to predict the potential breeding applications of such markers. (2) Evaluate the interaction of the ICRs with genetic backgrounds from multiple sources and of multiple levels of genetic variation, in order to predict the general applicability of molecular genetic marke
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Drug-resistant infections" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії